“Sequenom Patent Invalidation May Have Ramifications for NIPT Field, Entire MDx Industry” (featured quotes)
June 16, 2015GenomeWeb
Partner David Gass was quoted in GenomeWeb's article “Sequenom Patent Invalidation May Have Ramifications for NIPT Field, Entire MDx Industry” on June 16, 2015.